When a traumatic injury tears through bone and blood vessels alike, surgeons and patients face a race against time. Without immediate access to blood supply, cells deep within a large wound cannot survive, leaving patients facing permanent tissue loss or failed grafts. Now, researchers at UT San Antonio may have found the biological recipe that changes that equation.
A team of eight scientists has developed a natural protein scaffold that allows bone and blood vessels to regenerate simultaneously—a breakthrough that could transform how doctors treat severe bone injuries. Published in the journal Biomaterials Advances, the study identifies a precise 50:50 ratio of two proteins found naturally in the human body: collagen and fibrin. This balance creates what researchers call an interpenetrating polymer network, or IPN—essentially a microscopic architectural framework where different materials are interwoven to create a stable foundation for new growth.
"An IPN network is two things that are entangled like a giant mess of Legos," explains Teja Guda, the study's corresponding author and a distinguished professor of innovation and entrepreneurship in biomedical engineering and chemical engineering at UT San Antonio. "We are leaving all the building blocks there and letting the cells build whatever Lego structure they like the most."
The innovation lies in understanding what each protein does best. Fibrin, the protein the body naturally deploys to form blood clots after an injury, excels at recruiting the cells needed to grow new blood vessels—a process scientists call angiogenesis. Collagen, the primary structural protein in bones, provides the mechanical strength that guides bone development, or osteogenesis. The challenge was finding the precise balance between these two competing demands.
To test their theory, the research team seeded the hydrogels with two critical biological components: microvascular fragments, which have the capacity to grow into blood vessels, and mesenchymal stem cells, which can develop into bone when given the right environmental cues. Rather than simply placing these cells on the scaffold's surface, the researchers embedded them directly into the liquid protein solution before it solidified, ensuring cells were suspended throughout the entire depth of the structure.
When the team tested five different protein ratios, the results were telling. Gels with higher fibrin concentrations sprouted blood vessels faster but lacked the stability for sustained bone growth. High-collagen gels were too rigid for vessels to penetrate effectively. The 50:50 blend proved to be the sweet spot. The microvascular fragments sprouted and branched into a robust, interconnected network while the mesenchymal stem cells developed in a stable environment, expressing the precise genetic markers needed to mature into bone-forming cells.
This dual-growth approach has profound implications for trauma medicine. Traditional treatments for severe bone loss rely on autografts—harvesting bone from elsewhere in the patient's body—or allografts from donors. Both approaches frequently fail because the transplanted bone lacks immediate blood supply, ultimately becoming necrotic and leading to high rates of clinical failure in complex trauma cases.
By ensuring that new bone forms while being continuously nourished by a developing vascular network, the UT San Antonio team has addressed one of surgery's most stubborn challenges. As Gennifer Chiou, the study's lead author and a postdoctoral fellow at UT San Antonio, notes: "We're looking at how we can regenerate both the tissue and the vessel itself within specifically bone tissue." This natural protein scaffold may finally give patients with the most devastating injuries a genuine path to healing.